title: [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
authors.affiliation: Department of Cardiology, Medical Faculty, Ege University, Izmir. mekay@med.ege.edu.tr
authors.forename: Meral
authors.initials: M
authors.lastname: Kayikçioğlu
authors.forename: Levent H
authors.initials: LH
authors.lastname: Can
authors.forename: Serdar
authors.initials: S
authors.lastname: Payzin
authors.forename: Hakan
authors.initials: H
authors.lastname: Kültürsay
authors.forename: Inan
authors.initials: I
authors.lastname: Soydan
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004452:Echocardiography; D004562:Electrocardiography; D011464:Epoprostenol / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D011464:Epoprostenol